The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Irritable Bowel Syndrome Therapy
Asafetida - Bismuth Subnitrate - Bryonia Alba Root - Activated Charcoal - Lycopodium Clavatum Spore - Sodium Carbonate - Strychnos Nux-Vomica Seed - Veratrum Album Root - · ASAFETIDA 3 [hp_X]/1; BISMUTH SUBNITRATE 6 [hp_X]/1; BRYONIA ALBA ROOT 6 [hp_X]/1; ACTIVATED CHARCOAL 6 [hp_X]/1; LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1; SODIUM CARBONATE 6 [hp_X]/1; STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/1; VERATRUM ALBUM ROOT 6 [hp_X]/1 · Tablet, Orally Disintegrating · Oral · TRP Company
NDC 17312-0019-14 · 1 BOTTLE in 1 PACKAGE / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Asafetida - Bismuth Subnitrate - Bryonia Alba Root - Activated Charcoal - Lycopodium Clavatum Spore - Sodium Carbonate - Strychnos Nux-Vomica Seed - Veratrum Album Root - (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| TRP Company | ASAFETIDA 3 [hp_X]/1; BISMUTH SUBNITRATE 6 [hp_X]/1; BRYONIA ALBA ROOT 6 [hp_X]/1; ACTIVATED CHARCOAL 6 [hp_X]/1; LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1; SODIUM CARBONATE 6 [hp_X]/1; STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/1; VERATRUM ALBUM ROOT 6 [hp_X]/1 | Aug 26, 2026 | Sep 2, 2026 |
| TRP Company | ASAFETIDA 6 [hp_X]/1; BISMUTH SUBNITRATE 3 [hp_X]/1; BRYONIA ALBA ROOT 6 [hp_X]/1; ACTIVATED CHARCOAL 6 [hp_X]/1; LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1; SODIUM CARBONATE 6 [hp_X]/1; STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/1; VERATRUM ALBUM ROOT 6 [hp_X]/1 | Jul 22, 2026 | Aug 19, 2026 |
| TRP Company | ACTIVATED CHARCOAL 6 [hp_X]/1; ASAFETIDA 3 [hp_X]/1; BISMUTH SUBNITRATE 6 [hp_X]/1; BRYONIA ALBA ROOT 6 [hp_X]/1; LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1; SODIUM CARBONATE 6 [hp_X]/1; STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/1; VERATRUM ALBUM ROOT 6 [hp_X]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Irritable Bowel Syndrome Therapy — NDC 17312-0019-14," retrieved September 3, 2026, https://drugdashboards.com/drug/17312001914.
Free to cite with attribution — see how the data is put together.